Jul 2026
Drug-likeness defects drive carrier-free cyanine-PROTAC self-assembly for tumor-specific protein degradation.
A versatile supramolecular strategy that directly addresses the long-standing delivery challenges of PROTACs and advances precise, controllable oncological therapy is established.
Zhenhai Pan, Taian Lin, I. Ullah et al.
· Journal of Controlled Releas... · 0 citations